AHFTC Board Certification Review Early Bird Registration ends April 26

HFSA AHFTC Board Certification Review 2024

July 12, 2024 - July 14, 2024 | Chicago, IL

Agenda

The HFSA AHFTC Board Certification Review 2024 will be comprised of renowned heart failure experts presenting curriculum that has been tailored to the actual ABIM examination blueprint. The course will take place over three (3) days (July 12-14, 2024) and include the components outlined below.

All sessions are listed in Central Standard Time.

Intended Audience

The 2024 HFSA AHFTC Board Certification Review is designed for physicians who are preparing to take the ABIM Advanced Heart Failure and Transplant Cardiology Certification Examination or the Maintenance of Certification Assessment Examination, or heart failure specialists seeking an in-depth review in heart failure.

Pre-Meeting Webinars
  • Heart Failure Epidemiology and Risk Factors
     
  • Pathophysiology 1: Cellular and Energetic Considerations
    Daniel Burkhoff, MD, PhD
     
  • Pathophysiology 2: Hemodynamic, Structural and Neurohormonal Considerations
    Daniel Burkhoff, MD, PhD
     
  • Diagnosis and Clinical Assessment
    Mark Drazner, MD, MSc, FHFSA
     
  • Cardio-Oncology for the HF Boards
     
  • Clinico-Pathologic Correlates in Heart Failure/ Images for the Heart Failure Boards
    Jon W. Lomasney, MD
     
  • Statistics for the HF Board
    Brian Claggett, PhD
     
  • Hemodynamics in HF I
    James C. Fang, MD, FHFSA
     
  • Diabetes and COPD
    Maria Rosa Costanzo, MD, FHFSA
     
  • RV Failure and TR Management
    Barry A. Borlaug, MD
     
  • Management of Comorbidities in Heart Failure - Sleep Disorders
    Maria Rosa Costanzo, MD, FHFSA
     
  • Healthcare Disparities in HF
    Khadijah Breathett, MD, MS, FHFSA
     
  • Issues in Chronic HF Disease Management (Biomarkers, Remote Monitoring, Lifestyle Interventions)
    Akshay S. Desai, MD, MPH, FHFSA
08:30 am - 08:45 am

Welcome and HFSA Introduction

Nancy Sweitzer, MD, PhD, FHFSA and Maria Rosa Costanzo, MD, FHFSA

08:45 am - 09:15 am

Live ABIM Style Question Session

Nancy Sweitzer, MD, PhD, FHFSA and Maria Rosa Costanzo, MD, FHFSA

09:15 am - 09:45 am

Hemodynamics in HF II

James C. Fang, MD, FHFSA

09:45 am - 10:15 am

Optimal Medical Therapy for HFrEF 1

Mark Drazner, MD, MSc, FHFSA

10:15 am - 10:45 am

Optimal Medical Therapy for HFrEF 2

Mark Drazner, MD, MSc, FHFSA

10:45 am - 11:00 am

REFRESHMENT BREAK

11:00 am - 11:30 am

Cardio Renal Failure Interactions in Heart Failure

11:30 am - 12:00 pm

Assessment of Functional Capacity Including Cardiopulmonary Exercise Testing

Gregory Lewis, MD

12:00 pm - 12:30 pm

Q&A - Faculty

12:30 pm - 01:30 pm

LUNCH

01:30 pm - 02:00 pm

HFpEF: Epidemiology, Risk Factors, Diagnosis, Management (For the Boards)

Sanjiv Shah, MD

02:00 pm - 02:30 pm

Management of Comorbidities in Heart Failure: Iron Deficiency/Anemia

Gregory Lewis, MD

02:30 pm - 03:00 pm

Pulmonary Hypertension: Classification and Initial Evaluation

Jonathan Rich, MD, FHFSA

03:00 pm - 03:30 pm

Pulmonary Hypertension: Treatment

Jonathan Rich, MD, FHFSA

03:30 pm - 03:45 pm

REFRESHMENT BREAK

03:45 pm - 04:15 pm

Specific Etiologies of HF 1: HCM

Jane Wilcox, MD, MSc, FHFSA

04:15 pm - 04:45 pm

Specific Etiologies of HF 2: Other Inherited HF syndromes

Jane Wilcox, MD, MSc, FHFSA

04:45 pm - 05:15 pm

Specific Etiologies of HF 3: Infiltrative Disorders and Restrictive CMP

Sanjiv Shah, MD

05:15 pm - 05:45 pm

Q&A - Faculty

08:00 am - 08:15 am

Welcome & HFSA Introduction, Practice Question

Nancy Sweitzer, MD, PhD, FHFSA and Maria Rosa Costanzo, MD, FHFSA

08:15 am - 08:45 am

Specific Etiologies of HF 4: Myocarditis and Inflammatory Cardiomyopathies

Maria Rosa Costanzo, MD, FHFSA

08:45 am - 09:15 am

Management of the Hospitalized HF Patient

Maria Rosa Costanzo, MD, FHFSA

09:15 am - 09:45 am

Advanced Heart Failure: Defining the Phenotype and Patient Selection for Advanced Therapies

Nancy Sweitzer, MD, PhD, FHFSA

09:45 am - 10:00 am

REFRESHMENT BREAK

10:00 am - 10:30 am

Immunology: The Basics, PRA, Sensitization, Crossmatch

Sean Pinney, MD, FHFSA

10:30 am - 11:00 am

Rejection: Cellular and Antibody Mediated

Sean Pinney, MD, FHFSA

11:00 am - 11:30 am

Heart Transplant, Clinical Outcomes and Complications

Michelle Kittleson, MD, PhD, FHFSA

11:30 am - 12:00 pm

Managing Immunosuppression and Drugs

Michelle Kittleson, MD, PhD, FHFSA

12:00 pm - 01:00 pm

Working Lunch

01:00 pm - 01:30 pm

Pregnancy in HF

Kathryn Lindley, MD

01:30 pm - 02:00 pm

Cardiogenic Shock Management

Nancy Sweitzer, MD, PhD, FHFSA

02:00 pm - 03:00 pm

MCS 1: Durable MCS Devices and Outcomes

Joseph G. Rogers, MD

03:00 pm - 03:15 pm

REFRESHMENT BREAK

03:15 pm - 03:45 pm

MCS 2: Temporary Support Devices and ECMO for the Boards

Manreet Kanwar, MD

03:45 pm - 04:15 pm

MCS 3: Management of Complications of MCS

Manreet Kanwar, MD

04:15 pm - 05:15 pm

MCS 4: Interactive Shock and Device Management

Daniel Burkhoff, MD, PhD, Manreet Kanwar, MD, Joseph G. Rogers, MD, and Nancy Sweitzer, MD, PhD, FHFSA

05:15 pm - 05:45 pm

Q&A - Faculty

08:00 am - 08:15 am

Welcome & HFSA Introduction, Practice Question

Nancy Sweitzer, MD, PhD, FHFSA and Maria Rosa Costanzo, MD, FHFSA

08:15 am - 08:45 am

Adult Congenital Heart Disease for the HF Specialist

Eric V. Krieger, MD

08:45 am - 09:15 am

Management of Left Sided Valvular Heart Disease in Heart Failure

Jane Wilcox, MD, MSc, FHFSA

09:15 am - 09:45 am

Management of Common Arrhythmias 1: Atrial Fibrillation and Flutter

Roderick Tung, MD

09:45 am - 10:15 am

Management of Common Arrhythmias 2: Ventricular Arrhythmia

Roderick Tung, MD

10:15 am - 10:30 am

REFRESHMENT BREAK

10:30 am - 11:00 am

Device Therapy in Heart Failure I: Sudden Death Prevention

Christine Albert, MD, MPH

11:00 am - 11:30 am

Device Therapy in Heart Failure II: CRT

Christine Albert, MD, MPH

11:30 am - 12:00 pm

Q&A - Faculty